Technical guidelines for therapeutic services open for comment
The Department of Health and Ageing has released draft technical guidelines for therapeutic services, open for consultation until 23 November 2013.
During this consultation process, and while revisions are made, applicants are advised by the department that they may use ‘Technical Guidelines for preparing assessment reports for the Medical Services Advisory Committee - Service Type: Therapeutic’ as a source of advice when developing submissions.
Following the consultation closing, comments will be reviewed and changes drafted for consideration by MSAC.
The 2013 consultation draft of the revised Technical Guidelines is published on the MSAC website, with a request for comment from any interested party. The guidelines and more information can be found at http://www.msac.gov.au.
The department seeks the views of stakeholders about the information included. Where incomplete, the views of stakeholders are also welcome about the proposed content or where additional content may be useful to an applicant. Feedback may be provided by email to the HTA Mailbox.
This is the first draft release, with others to follow for Investigative Services and Consultation Services. A date for the receipt of comment on the Technical Guidelines for investigative services will be set when it is released for comment. Comment for Technical Guidelines for consultative services will be managed separately.
AusBiotech members are invited to contribute comment for the AusBiotech submission and may be directed to Programs Manager Alina Tooley at atooley@ausbiotech.org or 03 9828 1400.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
